ConductScience.org, home

Gene · 4205

NIH grants3,969

NIH grants whose papers are about the gene, through NIH's grant-paper links.

121 to 140 of 3,969

Download this page as JSON
GrantTitleMEF2A papersNewest fiscal year
U19AG023122Longevity Consortium22025
U24AG041689THE NIA GENETICS OF ALZHEIMER'S DISEASE DATA STORAGE SITE22025
U24CA196171The Alliance NCTN Biorepository and Biospecimen Resource22025
U24CA196172ECOG-ACRIN Biospecimen Bank to Support NCTN22025
U54GM115516Northern New England Clinical and Translational Research Network22025
U54MD007600Center for Collaborative Research in Health Disparities22025
UL1TR001863Yale Clinical and Translational Science Award22025
ZIAAR041126Control of Adult and Aging Myogenesis22025
ZIABC010999Targeting FGFR4, RAS, and PAX3-FOXO1 gene in Rhabdomyosarcoma22025
ZIABC011722Genomic characterization and development of therapies for pediatric sarcoma22025
ZIADE000664Characterization of Molecular Pathways in Chronic Pain Conditions22025
ZICAG000616Analysis of complex biological systems by high-throughput genomic technologies22025
D43TW009744UNZA-Vanderbilt Training Partnership for HIV-NCD Research (UVP-2)12025
F30OD031914MicroRNA-375 regulation of enteroendocrine cell biology in diet-induced obesity and bariatric surgery12025
I01BX000163Leveraging mitochondrial function to combat radiation therapy-induced microvascular disease12025
I01BX002182Metabolic Regulation of Mucosal Inflammation12025
I01BX003648Vitamin D and Development Origins of Obesity and Insulin Resistance12025
K01HL164687Novel molecular mechanisms of vascular smooth muscle cell-mediated large and small artery calcification12025
K08HL159418Microfibril-associated glycoproteins attenuating pulmonary fibrosis12025
K08HL167699ADAR mediated RNA editing is a causal mechanism in coronary artery disease12025

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/4205/grants?page=7